PPCM
TEVA icon

Pillar Pacific Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Pillar Pacific Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-12,030
Closed -$206K – 302
2018
Q1 		$206K Sell
12,030
-250
-2% -$4.88K 0.02% 277
2017
Q4 		$233K Sell
12,280
-29,042
-70% -$437K 0.03% 268
2017
Q3 		$727K Sell
41,322
-52,691
-56% -$1.19M 0.09% 149
2017
Q2 		$3.12M Buy
94,013
+2,325
+3% +$72K 0.43% 98
2017
Q1 		$2.94M Buy
91,688
+8,359
+10% +$285K 0.42% 100
2016
Q4 		$3.02M Buy
83,329
+1,975
+2% +$78.9K 0.47% 94
2016
Q3 		$3.74M Buy
81,354
+2,285
+3% +$119K 0.59% 78
2016
Q2 		$3.97M Buy
79,069
+3,873
+5% +$206K 0.67% 65
2016
Q1 		$4.02M Buy
75,196
+3,095
+4% +$182K 0.7% 60
2015
Q4 		$4.73M Buy
72,101
+2,341
+3% +$145K 0.85% 41
2015
Q3 		$3.94M Buy
69,760
+1,228
+2% +$79.6K 0.74% 55
2015
Q2 		$4.05M Buy
68,532
+2,940
+4% +$181K 0.7% 66
2015
Q1 		$4.09M Buy
65,592
+3,905
+6% +$227K 0.72% 64
2014
Q4 		$3.55M Buy
61,687
+757
+1% +$42.2K 0.64% 73
2014
Q3 		$3.27M Buy
60,930
+2,155
+4% +$114K 0.6% 77
2014
Q2 		$3.08M Buy
58,775
+3,890
+7% +$199K 0.58% 79
2014
Q1 		$2.9M Sell
54,885
-475
-0.9% -$22K 0.59% 79
2013
Q4 		$2.22M Buy
55,360
+84
+0.2% +$3.31K 0.44% 92
2013
Q3 		$2.09M Buy
55,276
+4,051
+8% +$158K 0.46% 94
2013
Q2 		$2.01M Buy
+51,225
New +$1.99M 0.48% 90

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Pillar Pacific Capital Management's TEVA Position: Q2 2018 in Review

Pillar Pacific Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2018, closing a stake of 12,030 shares — an estimated $206K sold.

Pillar Pacific Capital Management first reported a position in TEVA in Q2 2013 and held it in 20 quarters. The position peaked at $4.73M in Q4 2015. 539 funds tracked by Wall St. Rank hold TEVA as of Q2 2018.

  • Pillar Pacific Capital Management reported no remaining Teva Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Pillar Pacific Capital Management sold 12,030 Teva Pharmaceuticals shares in Q2 2018, an estimated $206K.
  • Pillar Pacific Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 20 quarters.
  • Pillar Pacific Capital Management's Teva Pharmaceuticals position peaked at $4.73M in Q4 2015.
  • 539 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2018.

Based on Pillar Pacific Capital Management's 13F filing for Q2 2018, filed 7 Aug 2018.